About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
It's an experimental + mathematical paper explaining probable targets for Cetixumab resistance in colorectal cancer. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_egf",
"label": "EGF",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.initial_egf",
"description": "Initial EGF. Sets the initial value of bundled SBML symbol `EGF`."
},
{
"name": "initial_gnb5",
"label": "GNB5",
"units": "native SBML value",
"default": 0.5,
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.initial_gnb5",
"description": "Initial GNB5. Sets the initial value of bundled SBML symbol `GNB5`."
},
{
"name": "initial_meki",
"label": "MEKi",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.initial_meki",
"description": "Initial MEKi. Sets the initial value of bundled SBML symbol `MEKi`."
},
{
"name": "initial_erki",
"label": "ERKi",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.initial_erki",
"description": "Initial ERKi. Sets the initial value of bundled SBML symbol `ERKi`."
},
{
"name": "initial_akti",
"label": "AKTi",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.initial_akti",
"description": "Initial AKTi. Sets the initial value of bundled SBML symbol `AKTi`."
},
{
"name": "initial_egfri",
"label": "EGFRi",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.initial_egfri",
"description": "Initial EGFRi. Sets the initial value of bundled SBML symbol `EGFRi`."
}
],
"outputs": [
{
"name": "egf",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.egf",
"description": "EGF observable. Maps to SBML symbol `EGF`."
},
{
"name": "gnb5",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.gnb5",
"description": "GNB5 observable. Maps to SBML symbol `GNB5`."
},
{
"name": "meki",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.meki",
"description": "MEKi observable. Maps to SBML symbol `MEKi`."
},
{
"name": "erki",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.erki",
"description": "ERKi observable. Maps to SBML symbol `ERKi`."
},
{
"name": "akti",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.akti",
"description": "AKTi observable. Maps to SBML symbol `AKTi`."
},
{
"name": "egfri",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.egfri",
"description": "EGFRi observable. Maps to SBML symbol `EGFRi`."
},
{
"name": "state",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Park2019 - Cetuximab resistance in colorectal cancer Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model_state"
],
"from": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.state"
},
{
"to": [
"visualisation.oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model_summary"
],
"from": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model_species_labels"
],
"from": "oncology_sbml_park2019_cetuximab_resistance_in_colorectal_canc_model1909300004_model.species_labels"
}
],
"package": "park2019-cetuximab-resistance-in-colorectal-cancer",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "It's an experimental + mathematical paper explaining probable targets for Cetixumab resistance in colorectal cancer. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagepark2019-cetuximab-resistance-in-colorectal-cancer
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisationother